{
    "eid": "2-s2.0-85113813835",
    "title": "Non-invasive tests for predicting liver outcomes in chronic hepatitis C patients: A systematic review and meta-analysis",
    "cover-date": "2021-08-27",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Hepatology",
            "@code": "2721",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Hepatitis C virus",
        "Hepatocellular carcinoma",
        "Liver-related outcomes",
        "Mortality",
        "Non-invasive tests",
        "Prognosis"
    ],
    "authors": [
        "Tanat Yongpisarn",
        "Chanattha Thimphitthaya",
        "Passisd Laoveeravat",
        "Nicha Wongjarupong",
        "Roongruedee Chaiteerakij"
    ],
    "citedby-count": 3,
    "ref-count": 52,
    "ref-list": [
        "Prognostic value of liver fibrosis biomarkers: a meta-analysis",
        "Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis",
        "Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis",
        "EASL Recommendations on Treatment of Hepatitis C 2018",
        "Diagnosis and staging of fibrosis in patients with chronic hepatitis C: comparison and critical overview of current strategies",
        "Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases",
        "Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement",
        "Assessing bias in studies of prognostic factors",
        "A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy",
        "Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus",
        "Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores",
        "Non-invasive prediction of liver-related events in patients with HCVassociated compensated advanced chronic liver disease after oral antivirals",
        "Role of Liver Stiffness Measurement in Predicting HCC Occurrence in Direct-Acting Antivirals Setting: A Real-Life Experience",
        "Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis",
        "Liver stiffness measurement in the primary care setting detects high rates of advanced fibrosis and predicts liver-related events in hepatitis C",
        "Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohort",
        "Liver stiffness measurement predicts liver-related events in patients with chronic hepatitis C: A retrospective study",
        "Combining liver stiffness with hyaluronic acid provides superior prognostic performance in chronic hepatitis C",
        "Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short term",
        "Long-term prognostic value of the FibroTest in patients with non-alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease",
        "Liver steatosis is a major predictor of poor outcomes in chronic hepatitis C patients with sustained virological response",
        "Prognostic Value of Transient Elastography in Human Immunodeficiency Virus-Infected Patients With Chronic Hepatitis C",
        "Increased Mortality Among Persons With Chronic Hepatitis C With Moderate or Severe Liver Disease: A Cohort Study",
        "Liver stiffness predicts variceal bleeding in HIV/HCV-coinfected patients with compensated cirrhosis",
        "Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection",
        "Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study",
        "Shear wave elastography predicts hepatocellular carcinoma risk in hepatitis C patients after sustained virological response",
        "Risk assessment of hepatocellular carcinoma development by magnetic resonance elastography in chronic hepatitis C patients who achieved sustained virological responses by direct-acting antivirals",
        "Prediction of the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients after Sustained Virological Response by Aspartate Aminotransferase to Platelet Ratio Index",
        "Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography",
        "Aspartate Aminotransferase-to-Platelet Ratio or Fibros-4 Index Predicts the Development of Hepatocellular Carcinoma in Chronic Hepatitis C Patients with Sustained Virologic Response to Interferon Therapy",
        "Liver stiffness measurements in chronic hepatitis C: Treatment evaluation and risk assessment",
        "Prediction of liver stiffness hepatocellular carcinoma in chronic hepatitis C patients on interferon-based anti-viral therapy",
        "Aspartate aminotransferase to platelet ratio index and sustained virologic response are associated with progression from hepatitis C associated liver cirrhosis to hepatocellular carcinoma after treatment with pegylated interferon plus ribavirin",
        "Evaluation of hepatocellular carcinoma development in patients with chronic hepatitis C by EOB-MRI",
        "Advantage of liver stiffness measurement before and after direct-acting antiviral therapy to predict hepatocellular carcinoma and exacerbation of esophageal varices in chronic hepatitis C",
        "Liver Fibrosis and Body Mass Index Predict Hepatocarcinogenesis following Eradication of Hepatitis C Virus RNA by Direct-Acting Antivirals",
        "Prediction of Hepatocellular Carcinoma Development after Hepatitis C Virus Eradication Using Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein",
        "Clinical characteristics and prognosis of HCC occurrence after antiviral therapy for HCV patients between sustained and non-sustained responders",
        "Non-invasive prediction of hepatocellular carcinoma development using serum fibrosis marker in chronic hepatitis C patients",
        "Noninvasive serum models to predict significant liver related events in chronic hepatitis C",
        "Predictors of hepatocellular carcinoma occurrence after direct-acting antiviral therapy in patients with hepatitis C virus infection",
        "Fibrosis-4 index predicts mortality in HIV/HCV co-infected patients receiving combination antiretroviral therapy in rural China",
        "Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response",
        "Long-term outcome of hepatocellular carcinoma occurrence, esophageal varices exacerbation, and mortality in hepatitis C virus-related liver cirrhosis after interferon-based therapy",
        "Long-term prognosis of patients with chronic hepatitis C who did not receive interferon-based therapy: causes of death and analysis based on the FIB-4 index",
        "Design and validation of risk prediction model for hepatocellular carcinoma development after sustained virological response in patients with chronic hepatitis C",
        "Noninvasive in vivo liver fibrosis evaluation using supersonic shear imaging: a clinical study on 113 hepatitis C virus patients",
        "Magnetic resonance elastography for the noninvasive staging of liver fibrosis",
        "Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection",
        "Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update"
    ],
    "affiliation": [
        {
            "affiliation-city": "Minneapolis",
            "@id": "60029445",
            "affilname": "University of Minnesota Twin Cities",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029445",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Lexington",
            "@id": "60015941",
            "affilname": "University of Kentucky",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015941",
            "affiliation-country": "United States"
        }
    ],
    "funding": []
}